 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 June 2000 | Volume 132 Issue 11 | Pages 853-861
Background: The optimal duration of prophylaxis against venous thromboembolism after total hip or knee replacement is uncertain.
Objective: To determine the efficacy and safety of extended out-of-hospital prophylaxis with low-molecular-weight heparin (ardeparin sodium).
Design: Randomized, double-blind, placebo-controlled trial.
Setting: 33 community, university, or university-affiliated hospitals.
Patients: 1195 adults who had elective total hip or knee replacement and completed 4 to 10 days of postoperative ardeparin prophylaxis.
Intervention: Daily subcutaneous ardeparin (100 IU/kg of body weight) or placebo from time of hospital discharge to 6 weeks after surgery.
Measurements: Symptomatic, objectively documented venous thromboembolism or death, along with major bleeding, from time of hospital discharge to 12 weeks after surgery.
Results: Patients who received ardeparin (n = 607) and those who received placebo (n = 588) did not differ significantly in the cumulative incidence of venous thromboembolism or death (9 cases [1.5%] compared with 12 cases [2.0%]; odds ratio, 0.7 [95% CI, 0.3 to 1.7]; P > 0.2; absolute difference, –0.56 percentage points [CI, –2.2 to 1.1 percentage points]) or major bleeding (2 cases [0.3%] compared with 3 cases [0.5%]).
Conclusions: Among patients who had total knee or total hip replacement and received 4 to 10 days of postoperative ardeparin prophylaxis, the cumulative incidence of symptomatic venous thromboembolism or death after hospital discharge was not significantly reduced by extended out-of-hospital ardeparin prophylaxis. Extended ardeparin use could provide a maximum 2.2–percentage point true reduction in such events. The benefit of extended ardeparin use is not clinically important for most patients. Future research should identify high-risk patients who would benefit most from extended prophylaxis.
*For members of the Ardeparin Arthroplasty Study Group, see Appendix.
Author and Article Information
From the Mayo Clinic and Foundation, Rochester, Minnesota; LDS Hospital and the University of Utah School of Medicine, Salt Lake City, Utah; Texas A&M University College of Medicine, Temple, Texas; and McMaster University, Hamilton, Ontario, Canada.
Acknowledgments: The authors thank the surgical, nursing, pharmacy, and support staff at all the study sites. They also thank Dr. D. Scott Holloway and Ms. Joanne DiLiberto, Wyeth-Ayerst Research.
Grant Support: By Wyeth-Ayerst Research, Philadelphia, Pennsylvania.
Requests for Single Reprints: John A. Heit, MD, Hematology Research, Plummer 549, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.
Current Author Addresses: Dr. Heit: Hematology Research, Plummer 549, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Dr. Elliott: LDS Hospital, University of Utah, Eighth Avenue and C Street, Salt Lake City, UT 84143.
Dr. Trowbridge: Texas A&M University, 2401 South 31st Street, Temple, TX 76508.
Dr. Morrey: Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.
Drs. Gent and Hirsh: Hamilton Civic Hospitals Research Centre, 711 Concession Street, Hamilton, Ontario L8V 1C3, Canada.
Author Contributions: Conception and design: C.G. Elliott, B.F. Morrey, J.A. Heit, J. Hirsh.
Analysis and interpretation of the data: C.G. Elliott, A.A. Trowbridge, M. Gent, J.A. Heit, J. Hirsh.
Drafting of the article: A.A. Trowbridge, M. Gent, J.A. Heit, J. Hirsh.
Critical revision of the article for important intellectual content: C.G. Elliott, A.A. Trowbridge, M. Gent, J.A. Heit, J. Hirsh.
Final approval of the article: C.G. Elliott, A.A. Trowbridge, B.F. Morrey, J.A. Heit, J. Hirsh.
Provision of study materials or patients: C.G. Elliott, A.A. Trowbridge, J.A. Heit, B.F. Morrey.
Statistical expertise: M. Gent.
Administrative, technical, or logistic support: M. Gent.
Collection and assembly of data: C.G. Elliott, J.A. Heit. ARTICLE
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement
A Randomized, Double-Blind, Placebo-Controlled Trial
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  W. H. Geerts, D. Bergqvist, G. F. Pineo, J. A. Heit, C. M. Samama, M. R. Lassen, and C. W. Colwell Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 381S - 453S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Singelyn, C. C.P.M. Verheyen, F. Piovella, H. K. Van Aken, N. Rosencher, and for the EXPERT Study Investigators The Safety and Efficacy of Extended Thromboprophylaxis With Fondaparinux After Major Orthopedic Surgery of the Lower Limb With or Without a Neuraxial or Deep Peripheral Nerve Catheter: The EXPERT Study Anesth. Analg., December 1, 2007; 105(6): 1540 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Skedgel, R. Goeree, S. Pleasance, K. Thompson, B. O'Brien, and D. Anderson The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty J. Bone Joint Surg. Am., April 1, 2007; 89(4): 819 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Friedman Optimal Duration of Prophylaxis for Venous Thromboembolism Following Total Hip Arthroplasty and Total Knee Arthroplasty J. Am. Acad. Ortho. Surg., March 1, 2007; 15(3): 148 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Motte, C. M. Samama, J. Guay, J. Barre, J.-Y. Borg, and N. Rosencher Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis: [La prevention de la thromboembolie veineuse postoperatoire. Evaluation du risque et methodes de prophylaxie] Can J Anesth, June 1, 2006; 53(6_suppl): S68 - S79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Schiff, S. R. Kahn, I. Shrier, C. Strulovitch, W. Hammouda, E. Cohen, and D. Zukor Identifying Orthopedic Patients at High Risk for Venous Thromboembolism Despite Thromboprophylaxis Chest, November 1, 2005; 128(5): 3364 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lieberman and W. K. Hsu Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty J. Bone Joint Surg. Am., September 1, 2005; 87(9): 2097 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. McGuire and P. P. Dobesh Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism Journal of Pharmacy Practice, October 1, 2004; 17(5): 289 - 307. [Abstract] [PDF]
|
|
|
|
|
|
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 338S - 400S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mosen, C. G. Elliott, M. J. Egger, M. Mundorff, J. Hopkins, R. Patterson, and R. M. Gardner The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism Chest, May 1, 2004; 125(5): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kahn and J. S. Ginsberg Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome Arch Intern Med, January 12, 2004; 164(1): 17 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow The Prevention of Venous Thromboembolism in Older Adults: Guidelines J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): M42 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O'Donnell, L.-A. Linkins, C. Kearon, J. Julian, and J. Hirsh Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty: A Systematic Review Arch Intern Med, June 9, 2003; 163(11): 1362 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prandoni, O. Bruchi, P. Sabbion, C. Tanduo, A. Scudeller, C. Sardella, G. Errigo, F. Pietrobelli, G. Maso, and A. Girolami Prolonged Thromboprophylaxis With Oral Anticoagulants After Total Hip Arthroplasty: A Prospective Controlled Randomized Study Arch Intern Med, September 23, 2002; 162(17): 1966 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Whang and J. R. Lieberman Low-Molecular-Weight Heparin J. Am. Acad. Ortho. Surg., September 1, 2002; 10(5): 299 - 302. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Douketis, J. W. Eikelboom, D. J. Quinlan, A. R. Willan, and M. A. Crowther Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement: A Meta-analysis of Prospective Studies Investigating Symptomatic Outcomes Arch Intern Med, July 8, 2002; 162(13): 1465 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Hull, G. F. Pineo, P. D. Stein, A. F. Mah, S. M. MacIsaac, O. E. Dahl, M. Butcher, R. F. Brant, W. A. Ghali, D. Bergqvist, et al. Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty: A Systematic Review Ann Intern Med, November 20, 2001; 135(10): 858 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kher and M.M. Samama Low-Molecular-Weight Heparins: Weeks or Months Instead of Days of Treatment Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 314 - 320. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Kelly, A. Rudd, R.R. Lewis, and B.J. Hunt Screening for subclinical deep-vein thrombosis QJM, October 1, 2001; 94(10): 511 - 519. [Full Text] [PDF]
|
|
|
|
|
|
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler Prevention of Venous Thromboembolism Chest, January 1, 2001; 119(1_suppl): 132S - 175S. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. White, S. Gettner, J. M. Newman, K. B. Trauner, and P. S. Romano Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty N. Engl. J. Med., December 14, 2000; 343(24): 1758 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Davidson and A. W.A. Lensing Prolonged Prophylaxis after Joint Replacement: Another Step Sideways? Ann Intern Med, June 6, 2000; 132(11): 914 - 915. [Full Text] [PDF]
|
|
Article
